drugset / Trial / NCT02268773
Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To compare the combination of acetylsalicylic acid (25 mg) + modified-release dipyridamole (200 mg) bd versus acetylsalicylic acid (75 mg dispersible tablet once daily) in its effect on inhibition of thromboxane B2 formation
Timeline
- Start
- 2000-01
- Primary completion
- 2000-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 25 mg | — |
| Subject | Aspirin | Small molecule | 75 mg | — |
| Subject | Dipyridamole | Other / unclassified | 200 mg | — |
Indications
No indication recorded.